The evaluation of morbidity in gastrointestinal tumor patients underwent cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC)
Yusuf Emre Aytin, İbrahim Ethem Cakcak, Tamer Sağıroğlu
Similar Articles
Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of peritoneal metastasis
Selman Sökmen, Tayfun Bişgin, Berke Manoğlu, Canan Altay, Hülya Ellidokuz
Frequency of axillary nodal complete pathological response of breast cancer patients in neoadjuvant chemotherapy setting: A cross-sectional study
Syeda Sakina Abidi, Lubna Vohra, Asad Ali Kerawala, Annam Kafeel, Muhammad Umair Tahseen, Saad Javed
Integrating the new systemic treatment landscape and surgical therapy in hepatocellular carcinoma
Philipp K. Haber, Felix Krenzien, Kaya Sarıbeyoğlu, Johann Pratschke, Wenzel Schöning
Pathological complete response and associated factors in breast cancer after neoadjuvant chemotherapy: A retrospective study
Adnan Gündoğdu, Mehmet Uluşahin, Arif Burak Çekiç, Seher Nazlı Kazaz, Ali Güner
Surgical and survival outcomes of cytoreductive surgery alone or with perioperative intraperitoneal chemotherapy in high peritoneal cancer index
Metin Ercan, Mehmet Aziret, Kerem Karaman, Osman Köse, Volkan Öter, Hakan Yırgın, Ahmet Kaya, Yavuz Selim Kahraman, Elif Köse, Erdal Birol Bostancı, Orhan Ünal
Osteosarcoma metastatic to the thyroid gland: A rare case report
Selen Soylu, Tülin Öztürk, İrem Onur, Lebriz Uslu, Serkan Teksöz
Journal Metrics
| 2020 | 2021 | 2022 | |
| SCImago Journal Rank | 0.216 | 0.180 | 0.218 |
| CiteScore (Scopus) | 1.0 | 1.1 | 1.1 |
| CiteScore Rank (Scopus) | #279/422 | #291/469 | #312/495 |
| Journal Citation Indicator (Clarivate) | 234/271 (Q4) | 227/279 (Q4) | 230/286 (Q4) |
